These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2474103)

  • 1. Moderate sodium restriction, angiotensin converting enzyme inhibition, and thiazide diuretic in the management of essential hypertension.
    Singer DR; Markandu ND; Furnival L; Khoshnodi L; MacGregor GA
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S5-7. PubMed ID: 2474103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium restriction in hypertensive patients treated with a converting enzyme inhibitor and a thiazide.
    Singer DR; Markandu ND; Sugden AL; Miller MA; MacGregor GA
    Hypertension; 1991 Jun; 17(6 Pt 1):798-803. PubMed ID: 2045142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide.
    Buter H; Hemmelder MH; Navis G; de Jong PE; de Zeeuw D
    Nephrol Dial Transplant; 1998 Jul; 13(7):1682-5. PubMed ID: 9681711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind comparison of captopril and enalapril in mild to moderate hypertension.
    Vlasses PH; Conner DP; Rotmensch HH; Fruncillo RJ; Danzeisen JR; Shepley KJ; Ferguson RK
    J Am Coll Cardiol; 1986 Mar; 7(3):651-60. PubMed ID: 3005384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and endocrine changes associated with captopril in diuretic-resistant hypertensive patients.
    Fujita T; Ando K; Noda H; Sato Y; Yamashita N; Yamashita K
    Am J Med; 1982 Sep; 73(3):341-7. PubMed ID: 6751080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B; Cubela R; Johnston CI
    J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal changes with long-term converting-enzyme inhibition by captopril in essential hypertension.
    Matthews PG; McGrath BP; Johnston CI
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():135s-138s. PubMed ID: 232017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects of low-dose captopril plus a thiazide diuretic on mild to moderate essential hypertension: a multicenter double-blind comparison with propranolol. Captopril Research Group of Japan.
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S77-81. PubMed ID: 2580181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of low-dose captopril on mild to moderate essential hypertension.
    Abe K
    Adv Exp Med Biol; 1989; 247A():49-53. PubMed ID: 2690591
    [No Abstract]   [Full Text] [Related]  

  • 13. Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study.
    MacGregor GA; Markandu ND; Singer DR; Cappuccio FP; Shore AC; Sagnella GA
    Br Med J (Clin Res Ed); 1987 Feb; 294(6571):531-4. PubMed ID: 3103761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol.
    MacGregor GA; Markandu ND; Banks RA; Bayliss J; Roulston JE; Jones JC
    Br Med J (Clin Res Ed); 1982 Mar; 284(6317):693-6. PubMed ID: 6802291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of sodium intake on hydrochlorothiazide-induced changes in blood pressure, serum electrolytes, renin and aldosterone in essential hypertension.
    van Brummelen P; Schalekamp M; de Graeff J
    Acta Med Scand; 1978; 204(3):151-7. PubMed ID: 696414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and neurohumoral factors in the response of hypertensives to hydrochlorothiazide therapy.
    Fernandez PG; Snedden W; Nath C; Vasdev S; Lee C; Darke A
    Clin Invest Med; 1987 Nov; 10(6):513-9. PubMed ID: 3326694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with captopril, hydrochlorothiazide and pravastatin in dyslipidemic hypertensive patients.
    Waeber B; Greminger P; Riesen W; Darioli R; Simeon-Dubach D; Wunderlin R
    Blood Press; 1995 Nov; 4(6):358-62. PubMed ID: 8746603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.